SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Burcar Melody
(Last) (First) (Middle)
C/O VIRACTA THERAPEUTICS, INC.
2533 S COAST HWY 101, SUITE 210
(Street)
CARDIFF CA 92007
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/20/2024 		3. Issuer Name and Ticker or Trading Symbol
Viracta Therapeutics, Inc. [ VIRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP, Finance
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 11/14/2032 Common Stock 80,000 $2.985 D
Stock Option (Right to Buy) (2) 03/16/2033 Common Stock 47,500 $1.65 D
Stock Option (Right to Buy) (3) 03/12/2034 Common Stock 33,250 $0.985 D
Stock Option (Right to Buy) (4) 03/18/2034 Common Stock 100,000 $0.99 D
Explanation of Responses:
1. Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Issuer's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is September 30, 2022.
2. One forty-eight (1/48) of the shares subject to the option shall vest monthly beginning on the one month anniversary of January 1, 2023, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.
3. One forty-eight (1/48) of the shares subject to the option shall vest monthly beginning on the one month anniversary of January 1, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.
4. One forty-eight (1/48) of the shares subject to the option shall vest monthly beginning on the one month anniversary of March 18, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.
Remarks:
Exhibit 24: Power of Attorney
/s/ Melody Burcar 03/22/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.